Adverum Biotechnologies, Inc. – Common Stock(NASDAQ:ADVM) announced the earnings results for Fiscal Year 2016 and Q2. The results came in during After-hours on Aug 9, 2016. Earnings per share were $-0.36.
In a different note, On Jun 8, 2016, Chardan Capital said it Downgrades its rating on Adverum Biotechnologies, Inc. – Common Stock. In the research note, the firm Lowers the price-target to $7.50 per share. The shares have been rated ‘Neutral’ by the firm.